Lou Hawthorne
Vorstandsvorsitzender bei NaNotics LLC
Profil
Lou Hawthorne is the founder of NaNotics LLC.
Prior to that, he served as the Chief Executive Officer of Genetic Savings & Clone, Inc. from 1999 to 2007.
He obtained his undergraduate degree from Princeton University.
Aktive Positionen von Lou Hawthorne
| Unternehmen | Position | Beginn |
|---|---|---|
NaNotics LLC
 NaNotics LLC Packaged SoftwareTechnology Services NaNotics LLC develops nanomedical platform for treating major human and animal diseases. It provides NaNots a new nano-medical platform consisting of in vivo “extractors” that deplete from blood specific molecular signals or signal inhibitors that drive or enable disease progression. The company was founded by Lou Hawthorne and John Dodgson and is headquartered in Mill Valley, CA. | Vorstandsvorsitzender | 01.01.2015 |
Ehemalige bekannte Positionen von Lou Hawthorne
| Unternehmen | Position | Ende |
|---|---|---|
Genetic Savings & Clone, Inc.
 Genetic Savings & Clone, Inc. Agricultural Commodities/MillingProcess Industries Genetic Savings & Clone, Inc. is the pet gene bank and cloning company. The company sells cloned cats. The company is headquartered in Sausalito, CA. | Präsident | 20.08.2007 |
Ausbildung von Lou Hawthorne
| Princeton University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Genetic Savings & Clone, Inc.
Genetic Savings & Clone, Inc. Agricultural Commodities/MillingProcess Industries Genetic Savings & Clone, Inc. is the pet gene bank and cloning company. The company sells cloned cats. The company is headquartered in Sausalito, CA. | Process Industries |
NaNotics LLC
NaNotics LLC Packaged SoftwareTechnology Services NaNotics LLC develops nanomedical platform for treating major human and animal diseases. It provides NaNots a new nano-medical platform consisting of in vivo “extractors” that deplete from blood specific molecular signals or signal inhibitors that drive or enable disease progression. The company was founded by Lou Hawthorne and John Dodgson and is headquartered in Mill Valley, CA. | Technology Services |
